Bay Area's Portola Bangs Out a $150 Million Royalty Deal With

• Post author:Sam
• Post published:February 2, 2017
• Post category:BioPharma

  Life Sciences Jobs   ... Source: BioSpace

Continue ReadingBay Area's Portola Bangs Out a $150 Million Royalty Deal With

Envisia Therapeutics Releases Interim ENV515 (Travoprost XR) Phase II Data Demonstrating 11-Month Duration-Of-Action After A Single Dose In Patients With Glaucoma

• Post author:Sam
• Post published:February 2, 2017
• Post category:BioPharma

  Life Sciences Jobs   ... Source: BioSpace

Continue ReadingEnvisia Therapeutics Releases Interim ENV515 (Travoprost XR) Phase II Data Demonstrating 11-Month Duration-Of-Action After A Single Dose In Patients With Glaucoma

IntelliPharmaCeutics Announces FDA Acceptance For Filing Of NDA For Rexista (Oxycodone Hydrochloride Extended Release), An Abuse Deterrent Opioid Analgesic For The Treatment Of Moderate To Severe Pain

• Post author:Sam
• Post published:February 2, 2017
• Post category:BioPharma

  Life Sciences Jobs   ... Source: BioSpace

Continue ReadingIntelliPharmaCeutics Announces FDA Acceptance For Filing Of NDA For Rexista (Oxycodone Hydrochloride Extended Release), An Abuse Deterrent Opioid Analgesic For The Treatment Of Moderate To Severe Pain

New Jersey Implant Maker Braeburn Pharma Yanks Plans for $150 Million IPO

• Post author:Sam
• Post published:February 2, 2017
• Post category:BioPharma

  Life Sciences Jobs   ... Source: BioSpace

Continue ReadingNew Jersey Implant Maker Braeburn Pharma Yanks Plans for $150 Million IPO

EMA Publishes Clinical Study Reports for Two Generics

• Post author:Sam
• Post published:February 2, 2017
• Post category:Drug Industry Daily

The European Medicines Agency for the first time published data on its clinical data website from a withdrawn application, while adding clinical study reports for two generics. Source: Drug Industry…

Continue ReadingEMA Publishes Clinical Study Reports for Two Generics

FDA Civil Monetary Penalties Increase Across the Board to Keep Pace with Inflation

• Post author:Sam
• Post published:February 2, 2017
• Post category:Drug Industry Daily

The FDA’s civil monetary penalties are increasing to adjust for inflation at under 2 percent. Source: Drug Industry Daily

Continue ReadingFDA Civil Monetary Penalties Increase Across the Board to Keep Pace with Inflation

Anika Therapeutics To Issue Fourth-Quarter 2016 Financial Results And Business Highlights On Wednesday, February 15

• Post author:Sam
• Post published:February 1, 2017
• Post category:BioPharma

  Life Sciences Jobs   ... Source: BioSpace

Continue ReadingAnika Therapeutics To Issue Fourth-Quarter 2016 Financial Results And Business Highlights On Wednesday, February 15

Why Bay Area's Exelixis Surged 22% in January

• Post author:Sam
• Post published:February 1, 2017
• Post category:BioPharma

  Life Sciences Jobs   ... Source: BioSpace

Continue ReadingWhy Bay Area's Exelixis Surged 22% in January

5 Things Illumina's Management Wants You to Know

• Post author:Sam
• Post published:February 1, 2017
• Post category:BioPharma

  Life Sciences Jobs   ... Source: BioSpace

Continue Reading5 Things Illumina's Management Wants You to Know

Pfizer Turns to to Explore $2 Billion Sale of Certain Assets

• Post author:Sam
• Post published:February 1, 2017
• Post category:BioPharma

  Life Sciences Jobs   ... Source: BioSpace

Continue ReadingPfizer Turns to to Explore $2 Billion Sale of Certain Assets